11/05/15: How can we ensure the promise of personalized medicine reaches patients?

Back to Top

Contributors:

      
Amy Miller, Executive Vice President, PMC
Randy Burkholder, VP, Policy, PhRMA
Alan Balch, Chief Executive Office, NPAF

Join The Conversation

10/23/15: How does the Medicare Part D Extra Help program help patients?

Back to Top

Contributors:

      
Randall Rutta , President and CEO, Easter Seals, Inc.
Andrew Sperling, Director of Federal Legislative Advocacy, NAMI
Julie Ward, Director, Health Policy, The Arc

Join The Conversation

10/09/15: What needs to be done to ensure Hispanic patients have access to needed treatments?

Back to Top

Contributors:

      
Yanira Cruz, NHCOA President and CEO, NHCOA
Amy Hinojosa, Executive Director, MANA
Allen Gutierrez, National Executive Director , The Latino Coalition

Join The Conversation

09/25/15: How can we learn from previous disasters to plan for future ones as a community?

Back to Top

Contributors:

                
Robert Suter, D.O., Board of Directors, AAEM
Linda MacIntyre, Chief Nurse, The Red Cross
Jim Aiken, M.D., Associate Clinical Professor of Emergency Medicine and Public Health, ACEP
Frank Caruso PA-C, Chairman, PAs in Disaster Medicine, AAPA, SIG-Disaster Med
Emily Lord, Executive Director, Healthcare Ready
Nicolette Louissaint, Director of Programming, Healthcare Ready
Kathleen Jaeger, Senior Vice President for Pharmacy Care and Patient Advocacy, NACDS
Lauren Wiesner, M.D., Director of Emergency Preparedness for the Emergency Department, MedStar Washington Hospital Center

Join The Conversation

08/24/15: What are you most excited about in the fight against cancer?

Back to Top

Contributors:

          
Eric Rubin, Vice President & Therapeutic Area Head, Merck
Vicki Kennedy, Attorney, Greenberg Traurig LLP
Rick Dunetz, Executive Director and Founder, Side-Out Foundation
J. Silvio Gutkind, Associate Director, Basic Science, Moores Cancer Center
Jay Scott, Co-Executive Director, Alex’s Lemonade Stand

Join The Conversation

07/24/15: Here’s what leading experts in Alzheimer’s are saying about research and innovation.

Back to Top

Contributors:

        
George Scangos, CEO, Biogen
Sue Peschin, President and CEO, Alliance for Aging Research
Robert Egge, VP, Public Policy, Alzheimerʼs Association
Dr. Bill Chin, Chief Medical Officer and EVP, PhRMA

Join The Conversation

07/02/15: What advancements can we celebrate 25 years after passage of the Americans with Disabilities Act?

Back to Top

Contributors:

        
Donna Meltzer, CEO, NACDD
Sara Weir, President, NDSS
Heather Ansley, Associate General Counsel for Corporate and Government Relations, PVA
Helena Berger, Acting President & CEO, AAPD

Join The Conversation

06/18/15: How do you define patient-centered drug development and how does it impact the people you represent?

Back to Top

Contributors:

        
Susan Manzi, Chair of the Department of Medicine, Allegheny Health Network
Eric Hargis , CEO, Colon Cancer Alliance
Todd Gillenwater, Executive Vice President, CLSA
Jon Retzlaff, Managing Director of Science Policy and Government Affairs, AACR

Join The Conversation

06/04/15: What advancements in the treatment of HIV/AIDS should be celebrated during the anniversary of the Ryan White Care Act?

Back to Top

Contributors:

      
Carl Schmid, Deputy Executive Director, The AIDS Institute
Marvell Terry II, HIV/AIDS Fellow, Human Rights Campaign
Kathie Hiers, CEO, AIDS Alabama

Join The Conversation

Pages